Search
Perfluorodecalin
go.drugbank.com/drugs/DB16292Investigationalis under investigation in clinical trial NCT03668665 (Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From
Diphenidol
go.drugbank.com/drugs/DB01231ApprovedWithdrawnDiphenidol is an antiemetic agent used in the treatment of vomiting and vertigo. Diphenidol overdose may result in serious toxicity in children.
mTOR Signaling pathway
smpdb.ca/view/SMP0535455SignalingCellular energy status is sensed by AMPK, which upon activation by a high AMP/ATP ratio phosphorylates TSC2 and the mTORC1 subunit Raptor to inhibit mTORC1, whereas high ATP from glycolysis suppresses … Amino acids signal through distinct routes: Leucine binds to CASTOR1 to dissociate it from GATOR2, blocking GATOR1 and enabling RagA/B‑GTP loading to recruit mTORC1 to lysosomes; Arginine is sensed by
Enzymes: Cytosolic arginine sensor for mTORC1 subunit 1Erythroxylum catuaba bark
go.drugbank.com/drugs/DB14300Investigational"Catuaba" is a general term for a medicinal infusion created by the bark of plants belonging to the _Erythroxylum_ genus, though this name is also applied to infusions of plants belonging to other genera … [A215262] The infusion is thought to carry stimulant and aphrodisiac effects,[A215262] and catuaba made specifically with _Trichilia catigua_ has been investigated for use in depression.[A215267]
Ala-geninthiocin
go.drugbank.com/drugs/DB15657ExperimentalAla-geninthiocin is a novel thiopeptide antibacterial compound derived from marine _Streptomyces_ species.
Dialyzable leukocyte extract
go.drugbank.com/drugs/DB16530InvestigationalTransferon is comprised of several peptides mixed from human dialyzable leucocyte extracts and acts as an immunomodulator.
Aspergillus repens
go.drugbank.com/drugs/DB10449ApprovedAspergillus repens is a fungus which can provoke allergic reactions. Aspergillus repens extract is used in allergenic testing.
Mixtures: Number Four Mold MixtureCERE-110
go.drugbank.com/drugs/DB05898InvestigationalThis drug is developed by Ceregene and currently under phase I of clinical trial.
Esmirtazapine
go.drugbank.com/drugs/DB06678InvestigationalMerck has terminated its internal clinical development program for esmirtazapine as of March 2010. … Esmirtazapine, known by the standardized identifier SCH 900265, was under development by Organon to treat insomnia and vasomotor symptoms associated with menopause.
PPI-2458
go.drugbank.com/drugs/DB05864InvestigationalClinical development with previous fumagillin derivatives has been limited by their toxicity profile.